Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128270 · ClinicalTrials.gov registry record · Phase 1
Pharmacotoxicology of Trichloroethylene Metabolites
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT01128270 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 27 participants.
The verdict
NCT01128270, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This is a research study to look at how Dichloroacetate (DCA), and investigational drug and chloral hydrate are broken down in the body. The purpose of the study is to better understand how humans metabolize these two common chemicals that are widely present in the environment. The study focuses on how the drug chloral hydrate is broken down and how it effects DCA
Interventions
- DRUG Dichloroacetate environmental dose
- DRUG Chloral Hydrate environmental dose
- DRUG Dichloroacetate therapeutic dose
- DRUG Chloral Hydrate therapeutic dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01128270
The ClinicalTrials.gov registry entry for NCT01128270 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Dichloroacetate environmental dose is the first listed.
NCT01128270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01128270 about?
NCT01128270 is a clinical study titled "Pharmacotoxicology of Trichloroethylene Metabolites". This is a research study to look at how Dichloroacetate (DCA), and investigational drug and chloral hydrate are broken down in the body. The purpose of the study is to better understand how humans metabolize these two common chemicals that are widely present in the environment. The study focuses on ...
What is the current status of trial NCT01128270?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2010-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01128270?
The interventions under investigation include: Dichloroacetate environmental dose (DRUG), Chloral Hydrate environmental dose (DRUG), Dichloroacetate therapeutic dose (DRUG), Chloral Hydrate therapeutic dose (DRUG).
Who is sponsoring clinical trial NCT01128270?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.